Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials
Palabras clave :
Selective internal radiation
SIRT
TARE
TACE
Outcome
Transplantation rates
Fecha de publicación :
2018
Editorial :
Taylor and Francis Group
Nota:
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Cita:
Casadei-Gardini, A. (Andrea); Tamburini, E. (Emiliano); Iñarrairaegui, M. (Mercedes); et al. "Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials". Oncotargets and therapy. 2018 (11), 2018, 7315 - 7321
Aparece en las colecciones:
Estadísticas e impacto
0 citas en
0 citas en
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.